trial · primary record
LTZ-232
Colorectal Cancer
| Phase | Phase 1 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 152 |
| Primary completion | 2031-12 |
| Primary endpoint | Characterize the Safety and Tolerability of LTZ-232 in metastatic colorectal cancer and other solid tumors using the incidence, severity, and type of adverse events according to CTCAE v5.0. |
| Registry ID | NCT07878988 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-04T03:56:16.937Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07878988
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.